What is driving listed private equity?

clock • 3 min read

With discounts on listed private equity trusts almost back to long-term averages, value in the sector can be hard to find. But Ben Williams, investment manager at Saunderson House, argues the improving merger and acquisition market is likely to benefit the asset class in 2015

The outperformance of listed private equity investments over traditional quoted equity markets, such as the FTSE All Share index, continued in 2014, much the same as it has over the past several decades (see chart 1). This outperformance has primarily been driven by the potential for private equity managers to participate in a large and growing marketplace of non-public, high-growth companies not available to mainstream investors, as well as their ability to create value by proactively influencing and interacting with invested companies' management, and taking more aggressive operational ...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
European private equity yet to spend €270bn worth of capital

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Early-stage biopharma: An opportunity for strategic investment

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot